Literature DB >> 21544583

Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra.

E Merlin, L Berthomieu, C Dauphin, J L Stéphan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21544583     DOI： 10.1007/s00246-011-0009-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  9 in total

Review 1.  Cardiac tamponade in juvenile chronic arthritis: report of two cases and review of publications.

Authors:  J Goldenberg; A P Pessoa; S Roizenblatt; R M Pávoa; M O Hilário; E Atra; M B Ferraz
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  Cardiac involvement in juvenile rheumatoid arthritis.

Authors:  B Bernstein; M Takahashi; V Hanson
Journal:  J Pediatr       Date:  1974-09       Impact factor: 4.406

3.  Juvenile rheumatoid arthritis with cardiac tamponade.

Authors:  H A Majeed; J Kvasnicka
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

Review 4.  Cardiac tamponade in Still disease: a review of the literature.

Authors:  Najma Parvez; John L Carpenter
Journal:  South Med J       Date:  2009-08       Impact factor: 0.954

5.  Symptomatic cardiac involvement in juvenile rheumatoid arthritis.

Authors:  J Goldenberg; M B Ferraz; A P Pessoa; A S Fonseca; A C Carvalho; M O Hilario; E Atra
Journal:  Int J Cardiol       Date:  1992-01       Impact factor: 4.164

6.  Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Authors:  Shumpei Yokota; Tomoyuki Imagawa; Masaaki Mori; Takako Miyamae; Yukoh Aihara; Shuji Takei; Naomi Iwata; Hiroaki Umebayashi; Takuji Murata; Mari Miyoshi; Minako Tomiita; Norihiro Nishimoto; Tadamitsu Kishimoto
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

7.  Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.

Authors:  T Lequerré; P Quartier; D Rosellini; F Alaoui; M De Bandt; O Mejjad; I Kone-Paut; M Michel; E Dernis; M Khellaf; N Limal; C Job-Deslandre; B Fautrel; X Le Loët; J Sibilia
Journal:  Ann Rheum Dis       Date:  2007-10-18       Impact factor: 19.103

8.  Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?

Authors:  Paolo Picco; Giacomo Brisca; Francesco Traverso; Anna Loy; Marco Gattorno; Alberto Martini
Journal:  Arthritis Rheum       Date:  2009-01

9.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.

Authors:  Virginia Pascual; Florence Allantaz; Edsel Arce; Marilynn Punaro; Jacques Banchereau
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307
  9 in total
  4 in total

1.  Anakinra for myocarditis in juvenile idiopathic arthritis.

Authors:  Rajesh Movva; Suzanne B Brown; D Lynn Morris; Vincent M Figueredo
Journal:  Tex Heart Inst J       Date:  2013

Review 2.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan Dewitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

3.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

4.  Congenic mice provide evidence for a genetic locus that modulates spontaneous arthritis caused by deficiency of IL-1RA.

Authors:  Yanhong Cao; Xiaoyun Liu; Nan Deng; Yan Jiao; Yonghui Ma; Karen A Hasty; John M Stuart; Weikuan Gu
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.